GSK plc
GSK plc (GLAXF) Revenue
Annual & quarterly revenue history · segment & region breakdown
GLAXF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsGSK plc trailing twelve-month (TTM) revenue is $30.74B, an increase of 4.10% year-over-year from $32.66B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $32.66B | +$1.29B | +4.10% |
| 2024-12-31 | $31.38B | +$1.05B | +3.46% |
| 2023-12-31 | $30.33B | +$1.00B | +3.42% |
| 2022-12-31 | $29.32B | -$4.79B | -14.04% |
| 2021-12-31 | $34.11B | +$0.01B | +0.04% |
| 2020-12-31 | $34.10B | +$0.34B | +1.02% |
| 2019-12-31 | $33.75B | +$2.93B | +9.52% |
| 2018-12-31 | $30.82B | +$0.64B | +2.10% |
| 2017-12-31 | $30.19B | +$2.30B | +8.24% |
| 2016-12-31 | $27.89B | +$3.97B | +16.58% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare GLAXF revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income GSK plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
GSK plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in GBP.
Data sourced from GSK plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GLAXF revenue · 4 questionsGLAXF's trailing twelve-month (TTM) revenue is $30.74B. That is an increase of 4.10% year-over-year from $32.66B in FY2025.
▸ Source: FMP · GSK plc SEC filings · GAAP · GSK plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026